Demographic and clinical characteristics of healthy controls and patients with active, remitted, and cured CSa

Healthy ControlsPatients with Active CSPatients with Remitted CSPatients with Cured CSF2P Value
Age (yr)42.3 ± 10.441.9 ± 8.747.1 ± 10.041.4 ± 10.05.9NS
Sex (M/F)6:291:71:64:160.3NS
Years of education13.5 ± 3.414.4 ± 3.012.9 ± 2.313.4 ± 3.10.3NS
24-Hour urinary free cortisol133 ± 52543 ± 307152 ± 74122 ± 7526.3<.001b
Smoking status (nonsmoker/smoker/ex-smoker)12/12/117/1/02/4/19/5/610.4NS
Disease duration (mo)NA77.6 ± 77.444.6 ± 21.964.6 ± 34.00.99NS
Origin (pituitary/adrenal/ectopic/AIMAH)NA5/3/0/03/2/1/117/2/0/010.8NS
Hypertension (no/yes)35/04/43/413/720.9<.001c
Hypercholesterolemia (no/yes)31/47/17/017/31.2NS
Hypertriglyceridemia (no/yes)29/66/23/49/1110.5.015d
Central obesity (no/yes)25/102/60/79/1115.6.001e
Body mass indexg (no/overweight/obesity)22/11/22/5/11/3/38/9/312.6.049f
  • Note:—NS indicates not significant; AIMAH, ACTH-independent macronodular adrenal hyperplasia.

  • a Data are expressed as mean ± SD.

  • b Healthy controls vs active CS (<.001); active CS vs remitted CS (<.001); active CS vs cured CS (<.001).

  • c Healthy controls vs active CS (<.001); healthy controls vs remitted CS (<.001); healthy controls vs cured CS (<.001).

  • d Healthy controls vs remitted CS (.043); healthy controls vs cured CS (.006).

  • e Healthy controls vs active CS (.015); healthy controls vs remitted CS (.001).

  • f Healthy controls vs remitted CS (.015).

  • g Body mass index: normal, ≤25; overweight, 25–30; obesity, >30.